Valuation: COMPASS Pathways plc

Market Cap 1.65B 1.47B 1.37B 1.25B 2.36B 159B 2.39B 16.63B 6.44B 81.14B 6.21B 6.08B 261B P/E 2026 *
-5.55x
P/E 2027 * -7.13x
Enterprise Value 1.3B 1.15B 1.08B 981M 1.85B 125B 1.87B 13.02B 5.04B 63.54B 4.87B 4.76B 204B EV / Sales 2026 *
-
EV / Sales 2027 * 30.8x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day-3.94%
1 week-8.71%
Current month-3.94%
1 month-9.74%
3 months-10.08%
6 months+112.63%
Current year+73.19%
1 week 11.82
Extreme 11.82
13.49
1 month 11.82
Extreme 11.82
15.87
Current year 4.88
Extreme 4.88
15.87
1 year 4.88
Extreme 4.88
15.87
3 years 2.25
Extreme 2.25
15.87
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 67 01/03/2021
Date Insider Type Main position Quantity % Market Cap. Importance
03/08/26 Tax

Chief Executive Officer

-5,962 0.0062%
27/05/26 Free

Director

21,110 0.0220%
27/05/26 Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
-3.94%-8.71%+107.11%+61.49% 1.65B
+4.16%+3.04%+49.37%+94.17% 74.41B
-0.81%-1.28%+24.76%+78.67% 59.26B
+1.39%-0.42%+4.50%+34.79% 47.14B
-3.02%-5.20%+27.94%+32.51% 42.91B
+0.31%+3.02%+348.95%+643.82% 44.13B
-1.96%-0.33%+7.04%+99.46% 40.79B
+3.32%+3.49%+10.10%+51.23% 30.77B
-2.68%+2.92%+29.63%+22.72% 29.31B
-4.86%-10.66%-26.27%+330.06% 23.71B
Average -0.82%-1.34%+58.31%+144.89% 39.41B
Weighted average by Cap. +0.07%-0.35%+58.29%+145.51%

Financials

2026 *2027 *
Net sales - 39.7M 35.26M 32.97M 30.05M 56.57M 3.82B 57.35M 399M 154M 1.95B 149M 146M 6.25B
Net income -299M -265M -248M -226M -425M -28.75B -431M -3B -1.16B -14.64B -1.12B -1.1B -47.02B -252M -224M -209M -191M -359M -24.25B -364M -2.53B -980M -12.35B -946M -925M -39.67B
Net Debt -359M -319M -298M -272M -512M -34.56B -519M -3.61B -1.4B -17.6B -1.35B -1.32B -56.54B -432M -384M -359M -327M -616M -41.61B -624M -4.34B -1.68B -21.19B -1.62B -1.59B -68.06B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
01/10/26 $11.95 -3.94% 3,893,938
30/09/26 $12.44 -4.01% 3,052,122
29/09/26 $12.96 -2.04% 2,499,909
28/09/26 $13.23 +1.30% 1,782,301
25/09/26 $13.06 -0.23% 2,229,084
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
11.95USD
Average target price
23.75USD
Spread / Average Target
+98.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock